HighMark Wealth Management LLC

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1802451 ST. PAUL, MN

Position in PLRX

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$209,442

+$915 QoQ

Shares Held

166,224

-2.7% QoQ

Ownership

0.268%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

HighMark Wealth Management LLC holds $17,977,723 across 37 Biotechnology names. PLRX ranks #8 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CNTA	Centessa Pharmaceuticals plc	236,785	$9,405,100
2	ANAB	Anaptysbio, Inc	94,050	$3,477,338
3	EWTX	Edgewise Therapeutics, Inc.	53,179	$1,675,138
4	XENE	Xenon Pharmaceuticals Inc.	23,000	$1,337,450
5	CRNX	Crinetics Pharmaceuticals, Inc.	20,495	$744,378
6	AUPH	Aurinia Pharmaceuticals Inc.	35,196	$521,604
7	MDXG	Mimedx Group, Inc.	55,878	$220,718
8	PLRX	Pliant Therapeutics, Inc. This page	166,224	$209,442

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$209,442	166,224	-2.7%	Shares	Sole	2026-05-06
2025-12-31	$208,527	170,924	-22.0%	Shares	Sole	2026-02-05
2025-09-30	$324,120	219,000	+55.3%	Shares	Sole	2025-10-20
2025-06-30	$163,560	141,000	-10.5%	Shares	Sole	2025-07-21
2025-03-31	$212,625	157,500	+110.0%	Shares	Sole	2025-04-24
2024-12-31	$987,750	75,000	+11.1%	Shares	Sole	2025-01-31
2024-09-30	$756,675	67,500	0.0%	Shares	Sole	2024-10-17
2024-06-30	$725,625	67,500	+58.8%	Shares	Sole	2024-07-29
2024-03-31	$633,250	42,500	+80.9%	Shares	Sole	2024-04-29
2023-12-31	$425,585	23,500	—	Shares	Sole	2024-01-23
No filing history on record for this holder in this stock.